- Supported exchanges /
- F /
- 5GZ.F
WAVERLEY PHARMA INC. (5GZ F) stock market data APIs
Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom. It also focuses on generic oncology injectable products. The company offers generic oncology products, such as temozolomide, capecitabine, and erlotinib. It also provides injectable generic chemotherapy drugs, such as pemetrexed for the treatment of non-small cell lung cancer and other indications; and bortezomib to treat multiple myeloma and other indications. In addition, the company develops PARP-1 inhibitors for cancer treatment. Waverley Pharma Inc. was founded in 2014 and is headquartered in Winnipeg, Canada.
WAVERLEY PHARMA INC. Financial Data Overview
0.0065 | |
0.0065 | |
- | |
0.0065 | |
0.0065 | |
0.0065-0.0155 | |
543 K | |
54 000 K | |
145 K | |
1.37 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
WAVERLEY PHARMA INC. Fundamental Data is available in our Financial Data APIs
- Net Revenue 145 K
- EBITDA -939 664
- Earnings Per Share -0.02
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get WAVERLEY PHARMA INC. Earnings via APIs
- Latest Release 2024-08-26
- EPS/Forecast NaN
Get WAVERLEY PHARMA INC. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: